The device, which is being developed at the Universities of Bath and Bristol, is targeted at more than 750,000 patients who live with heart failure in the UK. More than […]
The device, which is being developed at the Universities of Bath and Bristol, is targeted at more than 750,000 patients who live with heart failure in the UK. More than […]